Thrombolytics in infectious endocarditis associated myocardial infarction

Alan J. Hunter, Donald E. Girard

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


The use of thrombolytics in the management of acute myocardial infarction in eligible patients is the accepted standard of practice. We present the case of an embolic myocardial infarction in the setting of acute infectious endocarditis, treated with thrombolytics, resulting in a massive intracerebral hemorrhage and the patient's death. Historical and current literature has shown a consistent and significant incidence of concurrent intracerebral mycotic aneurysms in the setting of infectious endocarditis. Despite this, a literature review of contraindications to the use of thrombolytics rarely recognizes endocarditis as a contraindication. It is imperative that the etiology for myocardial infarction be identified; if contraindications to thrombolytic treatment exist, alternative therapeutic interventions must be pursued. This case highlights the importance of the correct etiologic diagnosis of myocardial ischemia, and increases the awareness of the significant risks of intracerebral hemorrhage associated with the use of thrombolytics in the setting of endocarditis.

Original languageEnglish (US)
Pages (from-to)401-406
Number of pages6
JournalJournal of Emergency Medicine
Issue number4
StatePublished - Dec 18 2001


  • Bacterial myocardial infarction
  • Cerebral hemorrhage
  • Endocarditis
  • Thrombolytic therapy

ASJC Scopus subject areas

  • Emergency Medicine


Dive into the research topics of 'Thrombolytics in infectious endocarditis associated myocardial infarction'. Together they form a unique fingerprint.

Cite this